Erratum. Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial. Diabetes Care 2016;39:2042-2050

Lennart Tonneijck, Mark M. Smits, Marcel H.A. Muskiet, Trynke Hoekstra, Mark H.H. Kramer, A. H.Jan Danser, Piet M. Ter Wee, Michaela Diamant, Jaap A. Joles, Daniel H. van Raalte

Research output: Contribution to journalComment/Letter to the editorAcademic

Original languageEnglish
Number of pages1
JournalDiabetes Care
Issue number3
Publication statusPublished - 1 Mar 2019

Cite this